Europe Heart Transplant Market Forecast to 2030
Europe Heart Transplant Market Forecast to 2030 – Regional Analysis – by Surgery Type (Orthotopic Heart Transplant and Heterotopic Heart Transplant), Type (Donor Live Heart and Artificial Hearts), and End User (Hospitals, Cardiac Centers, and Others)
$2,840 – $4,440
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Increased Awareness of Organ Transplantation Drives Europe Heart Transplant Market
In Europe, efforts to raise awareness about heart transplantation include educational campaigns, collaboration between healthcare providers and organ procurement organizations, legislative initiatives, and public advocacy from medical professionals and organizations. These efforts aim to inform the public about the critical need for heart donors, address concerns or misconceptions, and encourage individuals to register as organ donors. Additionally, advancements in medical technology and surgical techniques have contributed to the success and viability of heart transplantation, further highlighting the importance of organ donation in saving lives. As a result, there has been an increasing acceptance and understanding of heart transplantation as a treatment option for end-stage heart failure within European countries.
Europe Heart Transplant Market Overview
The Europe heart transplant market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Europe occupies a significant position in the global heart transplant market and is estimated to register a notable CAGR during 2022-2030. The prevalence of cardiovascular diseases, leading to heart failure, contributes to the market growth in the region. Germany is an attractive market due to its consistent growth and innovative approach toward the healthcare sector. According to the Federal Statistical Office, health expenditure in Germany amounted to US$ 474 billion in 2021. The rising geriatric population with the increasing prevalence of chronic disease propels the heart transplant market growth in the country. With the growing age, many organs start to malfunction or become dysfunctional giving rise to organ transplantation procedures. Further, according to the WHO, ~4 in 10 deaths in Germany result from behavioural risk factors, including dietary risks, smoking, alcohol consumption, and low physical activity. In 2021, nearly 19% adults were obese in Germany. Obesity gives rise to various other health-related problems. Thus, public health issues such as obesity and overweight, resulting in chronic health disorders, can fuel the demand for organ transplantation procedures in Germany.
There is a gap between organ demand and organ donations in Germany. According to the German Foundation for Organ Transplantation (DSO), a total of 2,905 organs were donated post-mortem in 2021, in contrast to the need for 8,730 organs. Therefore, organ transplantation procedures are expected to grow in the coming years in the country significantly.
Europe Heart Transplant Market Revenue and Forecast to 2030 (US$ Million)
Europe Heart Transplant Market Segmentation
The Europe heart transplant market is segmented into surgery type, type, end user, and country.
Based on surgery type, the Europe heart transplant market is bifurcated into orthotopic heart transplantation and heterotopic heart transplantation. The orthotopic heart transplantation segment held a larger share of the Europe heart transplant market in 2022.
In terms of type, the Europe heart transplant market is bifurcated into donor live heart and artificial heart. The donor live heart segment held a larger share of the Europe heart transplant market in 2022. Further, artificial heart segment is categorized into ventricular assisted device and total artificial heart.
Based on end user, the Europe heart transplant market is segmented into hospitals, cardiac centres, and others. The hospitals segment held the largest share of the Europe heart transplant market in 2022.
Based on country, the Europe heart transplant market is segmented into Germany, France, the UK, Spain, Italy, and the Rest of Europe. Germany dominated the Europe heart transplant market in 2022.
Terumo Corp, Abbott Laboratories, SynCardia Systems LLC, BioVentrix Inc, Berlin Heart GmbH, LivaNova Plc, and Calon Cardio-Technology Ltd are some of the leading companies operating in the Europe heart transplant market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
According to the Research Team’ research, the Europe heart transplant market was valued at US$ 3,970.32 million in 2022 and is expected to reach US$ 8,789.67 million by 2030, registering a CAGR of 10.4% from 2022 to 2030. Increasing target disease incidence and growing geriatric population are among the critical factors attributed to the Europe heart transplant market expansion.
The geriatric population is prone to CVDs, orthopedic disorders, metabolic disorders, and neurological disorders, among others. According to the WHO, the aging population across the world is likely to rise from ~1 billion in 2019 to ~2.1 billion by 2050. As per European Commission’s data, as of January 1, 2023, the estimated population of the European Union was 448.8 million, with almost one-fifth (21.3%) of the population being 65 years of age or older. The EU’s population reached a median age of 44.5 years on January 1, 2023. This indicates that while half of the population of the EU was younger, the other half was older than 44.5 years. Hence, the growing elderly population, along with the increasing prevalence of heart failure, fuels the heart transplant market growth.
On the contrary, high cost of surgeries hampers the growth of Europe heart transplant market.
Based on surgery type, the Europe heart transplant market is bifurcated into orthotopic heart transplantation and heterotopic heart transplantation. The orthotopic heart segment held 78.4% share of Europe heart transplant market in 2022, amassing US$ 3,113.68 million. It is projected to garner US$ 7,001.02 million by 2030 to expand at 10.7% CAGR during 2022-2030.
In terms of type, the Europe heart transplant market is categorized into donor live heart, and artificial heart. The donor live heart segment held 73.6% share of Europe heart transplant market in 2022, amassing US$ 2,923.70 million. It is projected to garner US$ 6,361.02 million by 2030 to expand at 10.2% CAGR during 2022-2030. Further, artificial heart segment is categorized into ventricular assisted device and total artificial heart.
Based on end user, the Europe heart transplant market is segmented into hospitals, cardiac centers, and others. The hospitals segment held 59.4% share of Europe heart transplant market in 2022, amassing US$ 2,359.54 million. It is projected to garner US$ 5,344.60 million by 2030 to expand at 10.8% CAGR during 2022-2030.
By country, the Europe heart transplant market has been categorized into Germany, France, the UK, Spain, Italy, and the Rest of Europe. Our regional analysis states that Germany captured 27.0% share of Europe heart transplant market in 2022. It was assessed at US$ 1,070.00 million in 2022 and is likely to hit US$ 2,481.33 million by 2030, exhibiting a CAGR of 11.1% during 2022-2030.
Key players operating in the Europe heart transplant market are Terumo Corp, Abbott Laboratories, SynCardia Systems LLC, BioVentrix Inc, Berlin Heart GmbH, LivaNova Plc, and Calon Cardio-Technology, among others.
In June 2021, Abbott Laboratories announced that it has enhanced its capacity and supply for mechanical circulatory support (MCS) devices, Medtronic HeartWare ventricular assist device (HVAD). In addition, the company announced providing support training and education programs for its HeartMate 3 heart pump.
In January 2020, Abbott Laboratories announced that the Food and Drug Administration (FDA) approved its HeartMate 3 left ventricular assist device (LVAD). LVAD is a minimally invasive surgical technique for the placement that avoids open surgery. In 2017, the FDA approved HeartMate 3 for bridge therapy for patients awaiting a heart transplant.
o Highlights key business priorities to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in Europe heart transplant market , thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.
TABLE OF CONTENTS
1. Introduction
1.1 the Research Team’ Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Heart Transplant Market – Key Industry Dynamics
4.1 Heart Transplant Market – Key Industry Dynamics
4.2 Market Drivers
4.2.1 Increasing Target Disease Incidence
4.3 Market Restraints
4.3.1 High Cost of Surgeries
4.4 Market Opportunities
4.4.1 Increased Awareness of Organ Transplantation
4.5 Future Trends
4.5.1 Use of AI in Transplantation Procedures
4.6 Impact of Drivers and Restraints:
5. Heart Transplant Market – Europe Market Analysis
5.1 Heart Transplant Market Revenue (US$ Million), 2020-2030
5.2 Heart Transplant Market Forecast and Analysis
6. Europe Heart Transplant Market Analysis – Surgery Type
6.1 Overview
6.2 Orthotopic Heart Transplant
6.2.1 Overview
6.2.2 Orthotopic Heart Transplant Market, Revenue and Forecast to 2030 (US$ Million)
6.3 Heterotopic Heart Transplant
6.3.1 Overview
6.3.2 Heterotopic Heart Transplant Market, Revenue and Forecast to 2030 (US$ Million)
7. Europe Heart Transplant Market Analysis – Type
7.1 Overview
7.2 Donor Live Heart
7.2.1 Overview
7.2.2 Donor Live Heart Market, Revenue and Forecast to 2030 (US$ Million)
7.3 Artificial Hearts
7.3.1 Overview
7.3.2 Artificial Hearts Market, Revenue and Forecast to 2030 (US$ Million)
7.3.2.1 Ventricular Assisted Device
7.3.2.1.1 Ventricular Assisted Device Market, Revenue and Forecast to 2030 (US$ Million)
7.3.2.2 Total Artificial Heart
7.3.2.2.1 Total Artificial Heart Market, Revenue and Forecast to 2030 (US$ Million)
8. Europe Heart Transplant Market Analysis – End User
8.1 Overview
8.2 Hospitals
8.2.1 Overview
8.2.2 Hospitals Market, Revenue and Forecast to 2030 (US$ Million)
8.3 Cardiac Centers
8.3.1 Overview
8.3.2 Cardiac Centers Market, Revenue and Forecast to 2030 (US$ Million)
8.4 Others
8.4.1 Overview
8.4.2 Others Market, Revenue and Forecast to 2030 (US$ Million)
9. Europe Heart Transplant Market – Country Analysis
9.1 Europe
9.1.1 Europe Heart Transplant Market Overview
9.1.2 Europe Heart Transplant Market Revenue and Forecast and Analysis – By Country
9.1.2.1 Germany: Heart Transplant Market – Revenue and Forecast to 2030 (US$ Million)
9.1.2.1.1 Overview
9.1.2.1.2 Germany Heart Transplant Market Revenue and Forecast to 2030 (US$ Million)
9.1.2.1.3 Germany Heart Transplant Market Breakdown by Surgery Type
9.1.2.1.4 Germany Heart Transplant Market Breakdown by Type
9.1.2.1.4.1 Germany Heart Transplant Market Breakdown by Artificial Hearts
9.1.2.1.5 Germany Heart Transplant Market Breakdown by End User
9.1.2.2 France: Heart Transplant Market – Revenue and Forecast to 2030 (US$ Million)
9.1.2.2.1 Overview
9.1.2.2.2 France Heart Transplant Market Revenue and Forecast to 2030 (US$ Million)
9.1.2.2.3 France Heart Transplant Market Breakdown by Surgery Type
9.1.2.2.4 France Heart Transplant Market Breakdown by Type
9.1.2.2.4.1 France Heart Transplant Market Breakdown by Artificial Hearts
9.1.2.2.5 France Heart Transplant Market Breakdown by End User
9.1.2.3 United Kingdom: Heart Transplant Market – Revenue and Forecast to 2030 (US$ Million)
9.1.2.3.1 Overview
9.1.2.3.2 United Kingdom Heart Transplant Market Revenue and Forecast to 2030 (US$ Million)
9.1.2.3.3 United Kingdom Heart Transplant Market Breakdown by Surgery Type
9.1.2.3.4 United Kingdom Heart Transplant Market Breakdown by Type
9.1.2.3.4.1 United Kingdom Heart Transplant Market Breakdown by Artificial Hearts
9.1.2.3.5 United Kingdom Heart Transplant Market Breakdown by End User
9.1.2.4 Spain: Heart Transplant Market – Revenue and Forecast to 2030 (US$ Million)
9.1.2.4.1 Overview
9.1.2.4.2 Spain Heart Transplant Market Revenue and Forecast to 2030 (US$ Million)
9.1.2.4.3 Spain Heart Transplant Market Breakdown by Surgery Type
9.1.2.4.4 Spain Heart Transplant Market Breakdown by Type
9.1.2.4.4.1 Spain Heart Transplant Market Breakdown by Artificial Hearts
9.1.2.4.5 Spain Heart Transplant Market Breakdown by End User
9.1.2.5 Italy: Heart Transplant Market – Revenue and Forecast to 2030 (US$ Million)
9.1.2.5.1 Overview
9.1.2.5.2 Italy Heart Transplant Market Revenue and Forecast to 2030 (US$ Million)
9.1.2.5.3 Italy Heart Transplant Market Breakdown by Surgery Type
9.1.2.5.4 Italy Heart Transplant Market Breakdown by Type
9.1.2.5.4.1 Italy Heart Transplant Market Breakdown by Artificial Hearts
9.1.2.5.5 Italy Heart Transplant Market Breakdown by End User
9.1.2.6 Rest of Europe
9.1.2.6.1 Overview
9.1.2.6.2 Rest of Europe Heart Transplant Market Revenue and Forecast to 2030 (US$ Million)
9.1.2.6.3 Rest of Europe Heart Transplant Market Breakdown by Surgery Type
9.1.2.6.4 Rest of Europe Heart Transplant Market Breakdown by Type
9.1.2.6.4.1 Rest of Europe Heart Transplant Market Breakdown by Artificial Hearts
9.1.2.6.5 Rest of Europe Heart Transplant Market Breakdown by End User
10. Industry Landscape
10.1 Overview
10.2 Growth Strategies in the Heart Transplant Market
10.3 Inorganic Growth Strategies
10.3.1 Overview
10.4 Organic Growth Strategies
10.4.1 Overview
11. Company Profiles
11.1 Terumo Corp
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Abbott Laboratories
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 SynCardia Systems LLC
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 BioVentrix Inc
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Berlin Heart GmbH
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 LivaNova Plc
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Calon Cardio-Technology Ltd
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
12. Appendix
12.1 About the Research Team
LIST OF TABLES
Table 2. Heart Transplant Market Revenue and Forecast to 2030 (US$ Million)
Table 3. Heart Transplant Market Revenue and Forecast to 2030 (US$ Million) – Surgery Type
Table 4. Heart Transplant Market Revenue and Forecast to 2030 (US$ Million) – Type
Table 5. Heart Transplant Market Revenue and Forecast to 2030 (US$ Million) – End User
Table 6. Europe Heart Transplant Market Revenue and Forecast to 2030 (US$ Million) – By Country
Table 7. Germany Heart Transplant Market Revenue and Forecast to 2030 (US$ Million) – By Surgery Type
Table 8. Germany Heart Transplant Market Revenue and Forecast to 2030 (US$ Million) – By Type
Table 9. Germany Heart Transplant Market Revenue and Forecast to 2030 (US$ Million) – By Artificial Hearts
Table 10. Germany Heart Transplant Market Revenue and Forecast to 2030 (US$ Million) – By End User
Table 11. France Heart Transplant Market Revenue and Forecast to 2030 (US$ Million) – By Surgery Type
Table 12. France Heart Transplant Market Revenue and Forecast to 2030 (US$ Million) – By Type
Table 13. France Heart Transplant Market Revenue and Forecast to 2030 (US$ Million) – By Artificial Hearts
Table 14. France Heart Transplant Market Revenue and Forecast to 2030 (US$ Million) – By End User
Table 15. United Kingdom Heart Transplant Market Revenue and Forecast to 2030 (US$ Million) – By Surgery Type
Table 16. United Kingdom Heart Transplant Market Revenue and Forecast to 2030 (US$ Million) – By Type
Table 17. United Kingdom Heart Transplant Market Revenue and Forecast to 2030 (US$ Million) – By Artificial Hearts
Table 18. United Kingdom Heart Transplant Market Revenue and Forecast to 2030 (US$ Million) – By End User
Table 19. Spain Heart Transplant Market Revenue and Forecast to 2030 (US$ Million) – By Surgery Type
Table 20. Spain Heart Transplant Market Revenue and Forecast to 2030 (US$ Million) – By Type
Table 21. Spain Heart Transplant Market Revenue and Forecast to 2030 (US$ Million) – By Artificial Hearts
Table 22. Spain Heart Transplant Market Revenue and Forecast to 2030 (US$ Million) – By End User
Table 23. Italy Heart Transplant Market Revenue and Forecast to 2030 (US$ Million) – By Surgery Type
Table 24. Italy Heart Transplant Market Revenue and Forecast to 2030 (US$ Million) – By Type
Table 25. Italy Heart Transplant Market Revenue and Forecast to 2030 (US$ Million) – By Artificial Hearts
Table 26. Italy Heart Transplant Market Revenue and Forecast to 2030 (US$ Million) – By End User
Table 27. Rest of Europe Heart Transplant Market Revenue and Forecast to 2030 (US$ Million) – By Surgery Type
Table 28. Rest of Europe Heart Transplant Market Revenue and Forecast to 2030 (US$ Million) – By Type
Table 29. Rest of Europe Heart Transplant Market Revenue and Forecast to 2030 (US$ Million) – By Artificial Hearts
Table 30. Rest of Europe Heart Transplant Market Revenue and Forecast to 2030 (US$ Million) – By End User
Table 31. Recent Inorganic Growth Strategies in the Heart Transplant Market
Table 32. Recent Organic Growth Strategies in the Heart Transplant Market
LIST OF FIGURES
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. Heart Transplant Market Revenue (US$ Million), 2020-2030
Figure 4. Heart Transplant Market Share (%) – Surgery Type, 2022 and 2030
Figure 5. Orthotopic Heart Transplant Market Revenue and Forecast to 2030 (US$ Million)
Figure 6. Heterotopic Heart Transplant Market Revenue and Forecast to 2030 (US$ Million)
Figure 7. Heart Transplant Market Share (%) – Type, 2022 and 2030
Figure 8. Donor Live Heart Market Revenue and Forecast to 2030 (US$ Million)
Figure 9. Artificial Hearts Market Revenue and Forecast to 2030 (US$ Million)
Figure 10. Ventricular Assisted Device Market Revenue and Forecast to 2030 (US$ Million)
Figure 11. Total Artificial Heart Market Revenue and Forecast to 2030 (US$ Million)
Figure 12. Heart Transplant Market Share (%) – End User, 2022 and 2030
Figure 13. Hospitals Market Revenue and Forecast to 2030 (US$ Million)
Figure 14. Cardiac Centers Market Revenue and Forecast to 2030 (US$ Million)
Figure 15. Others Market Revenue and Forecast to 2030 (US$ Million)
Figure 16. Europe: Heart Transplant Market, by Key Country – Revenue (2022) (US$ Million)
Figure 17. Europe Heart Transplant Market Breakdown by Key Countries, 2022 and 2030 (%)
Figure 18. Germany Heart Transplant Market Revenue and Forecast to 2030 (US$ Million)
Figure 19. France Heart Transplant Market Revenue and Forecast to 2030 (US$ Million)
Figure 20. United Kingdom Heart Transplant Market Revenue and Forecast to 2030 (US$ Million)
Figure 21. Spain Heart Transplant Market Revenue and Forecast to 2030 (US$ Million)
Figure 22. Italy Heart Transplant Market Revenue and Forecast to 2030 (US$ Million)
Figure 23. Rest of Europe Heart Transplant Market Revenue and Forecast to 2030 (US$ Million)
Figure 24. Growth Strategies in the Heart Transplant Market
1. Terumo Corp
2. Abbott Laboratories
3. SynCardia Systems LLC
4. BioVentrix Inc
5. Berlin Heart GmbH
6. LivaNova Plc
7. Calon Cardio-Technology Ltd
You must be logged in to post a review.
Reviews
There are no reviews yet.